Holen Sie sich die Stockscreener-App
22.82
3.23%
0.715
Handel nachbörslich:
22.83
0.005
+0.02%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$22.11
Offen:
$21.99
24-Stunden-Volumen:
5.34M
Relative Volume:
0.73
Marktkapitalisierung:
$11.72B
Einnahmen:
$11.89B
Nettoeinkommen (Verlust:
$-560.00M
KGV:
-20.75
EPS:
-1.1
Netto-Cashflow:
$191.00M
1W Leistung:
-0.33%
1M Leistung:
-4.86%
6M Leistung:
-19.57%
1J Leistung:
-38.16%
1-Tages-Spanne:
$21.88
$22.87
1-Wochen-Bereich:
$21.63
$23.04
52-Wochen-Spanne:
$21.33
$37.74
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Vergleichen Sie BAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
22.82 | 11.36B | 11.89B | -560.00M | 191.00M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
436.39 | 156.20B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
188.35 | 53.50B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.15 | 39.84B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
74.08 | 35.89B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
261.26 | 18.87B | 2.96B | 487.70M | 344.00M | 6.6758 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-04 | Herabstufung | Stifel | Buy → Hold |
| 2025-08-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-02-26 | Fortgesetzt | Goldman | Buy |
| 2025-02-24 | Hochstufung | Argus | Hold → Buy |
| 2025-02-20 | Fortgesetzt | Barclays | Overweight |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Published on: 2025-10-13 23:44:46 - newser.com
Leading vs lagging indicators on Baxter International Inc. performancePortfolio Growth Summary & Fast Gaining Stock Strategy Reports - newser.com
Will Baxter International Inc. benefit from macro trendsTrade Risk Summary & Short-Term High Return Ideas - newser.com
Published on: 2025-10-13 09:32:46 - newser.com
Baxter International Inc. (BAX) Stock Analysis: A 27.56% Potential Upside with Dividend Yield of 3.10% - DirectorsTalk Interviews
Published on: 2025-10-13 04:36:01 - newser.com
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Sivik Global Healthcare LLC Sells 100,000 Shares of Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Why Baxter (BAX) Stock Is Falling Today - Yahoo Finance
Precision Trading with Baxter International Inc. (BAX) Risk Zones - news.stocktradersdaily.com
Baxter International Inc Options Spot-On: On July 31st, 222.65K Contracts Were Traded, With 75,527 Open Interest - 富途牛牛
What Fibonacci levels say about Baxter International Inc. reboundJuly 2025 Intraday Action & Community Trade Idea Sharing - newser.com
Saudi Arabia Dialysis Market Report 2025-2033, Competitive Analysis of Asahi Kasei, B. Braun Melsungen, Baxter Int'l, Becton Dickinson and Co, DaVita, Fresenius Medical Care, JMS, MedtronicResearchAndMarkets.com - The AI Journal
Baxter International (NYSE:BAX) Given Sell (D) Rating at Weiss Ratings - MarketBeat
Should you hold or exit Baxter International Inc. nowJuly 2025 Opening Moves & Real-Time Buy Signal Alerts - newser.com
Will Baxter International Inc. bounce back from current supportMarket Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Baxter Bros Inc. Grows Stock Position in Honeywell International Inc. $HON - MarketBeat
Dialysis Market See Incredible Growth 2025-2032 |Fresenius Medical Care, Baxter International, B Braun Melsungen AG Avitum, Nipro Corporation - industrytoday.co.uk
Can Baxter International Inc. (BTL) stock sustain free cash flowNew Guidance & AI Powered Market Trend Analysis - newser.com
Will Baxter International Inc. stock benefit from Fed rate cutsTrade Risk Report & Detailed Earnings Play Alerts - newser.com
How Baxter International Inc. stock performs during market turbulenceJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Baxter International (BAX) Receives a Buy from Evercore ISI - The Globe and Mail
Baxter International Sees Unusually Large Options Volume (NYSE:BAX) - MarketBeat
Evercore ISI Lowers Baxter International (NYSE:BAX) Price Target to $31.00 - MarketBeat
Evercore ISI Adjusts Baxter International Price Target to $31 From $33, Maintains Outperform Rating - MarketScreener
Evercore Maintains Baxter International Inc(BAX.US) With Buy Rating, Cuts Target Price to $31 - 富途牛牛
Is Baxter International Inc a good long term investmentHealthcare Stock Analysis & Learn the Secrets of Pro Traders - earlytimes.in
Risk vs reward if holding onto Baxter International Inc.Market Movers & High Accuracy Buy Signal Tips - newser.com
How the Narrative for Baxter International Is Evolving Amid Leadership Changes and Mixed Analyst Views - Yahoo
Detecting price anomalies in Baxter International Inc. with AI2025 EndofYear Setup & Fast Entry High Yield Tips - newser.com
Is Baxter International Inc. stock attractive for growth fundsWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
1 Healthcare Stock with Exciting Potential and 2 Facing Challenges - The Globe and Mail
Measuring Baxter International Inc.’s beta against major indices2025 Year in Review & Real-Time Stock Entry Alerts - newser.com
First bridge replacement finished after Helene, servicing Baxter Healthcare - WCNC
Will Baxter International Inc. stock beat Nasdaq index returns2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
Is Baxter International Inc. stock a buy on weaknessQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - newser.com
How Baxter International Inc. (BTL) stock performs in volatility spikesEarnings Trend Report & AI Enhanced Trading Alerts - newser.com
Healthcare Industry Resilience Collaborative (HIRC) Awards Gold Level Resiliency Badge to Baxter International Inc. (BAX) - MSN
What analysts say about Baxter International Inc stockGeopolitical Risk Analysis & Breakout Portfolio Performance - earlytimes.in
What drives PYXS stock priceRisk-Reward Ratio Analysis & Small Budget Trading Ideas - earlytimes.in
Baxter names new Senior VP and Chief Accounting Officer - MSN
Is Baxter International Inc BTL a good long term investmentEquity Performance Review & Rapid Capital Gain - earlytimes.in
Baxter International: Medical Business In Need Of A Save Itself (NYSE:BAX) - Seeking Alpha
Advanced analytics toolkit walkthrough for Baxter International Inc.Market Growth Summary & Precise Swing Trade Alerts - newser.com
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):